Mary Osbakken, MD, PhD named Somnus CMO

Somnus Therapeutics, Inc., (somnusthera.com )a private specialty pharmaceutical company in Bedminster that is developing a controlled-release sleep-maintenance therapeutic drug, today announced the formation of its executive development team. Somnus was founded in the summer of 2007 by Gary Cupit with Care Capital, a life sciences venture capital firm based in Princeton.

Mary Osbakken, MD, PhD, Chief Medical Officer, has 35 years of pharmaceutical industry (15 years) and academic (20 years) experience, most recently as CMO, at Inotek Pharmaceuticals Corporation. Prior positions included various senior roles in clinical development, business development and outcomes research at Aventis Pharmaceuticals, Covance and Bristol-Myers Squibb.